* Mondelli Mario

* Mondelli Mario

Università degli Studi di Pavia

H-index: 67

Europe-Italy

About * Mondelli Mario

* Mondelli Mario, With an exceptional h-index of 67 and a recent h-index of 33 (since 2020), a distinguished researcher at Università degli Studi di Pavia, specializes in the field of Infectious Diseases, Hepatology, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Selective metabolic interference with novel VA molecules targeting VDAC1 in cancer cells

VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference

Intrahepatic cholangiocarcinoma-derived organoids for disease modelling and drug screening

Long‐term dynamics of natural killer cells in response to SARS‐CoV‐2 vaccination: Persistently enhanced activity postvaccination

" Actionable" host genetic markers for repurposing" add-on therapy" in COVID-19

Non‐tuberculous mycobacteriosis of the liver responsive to empiric therapy

Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host’s Immunity

Hematuria following overtreatment of subconjunctival hemorrhage with heparin eye drops

* Mondelli Mario Information

University

Position

Dipartimento di Medicina Interna e Terapia Medica

Citations(all)

18174

Citations(since 2020)

5806

Cited By

14038

hIndex(all)

67

hIndex(since 2020)

33

i10Index(all)

170

i10Index(since 2020)

77

Email

University Profile Page

Università degli Studi di Pavia

Google Scholar

View Google Scholar Profile

* Mondelli Mario Skills & Research Interests

Infectious Diseases

Hepatology

Immunology

Top articles of * Mondelli Mario

Title

Journal

Author(s)

Publication Date

Selective metabolic interference with novel VA molecules targeting VDAC1 in cancer cells

Biophysical Journal

Stefano Conti Nibali

Silvia De Siervi

Enrico Luchinat

Andrea Magrì

Lorenza Brocca

...

2024/2/8

VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference

iScience

Stefano Conti Nibali

Silvia De Siervi

Enrico Luchinat

Andrea Magrì

Angela Messina

...

2024/4/30

Intrahepatic cholangiocarcinoma-derived organoids for disease modelling and drug screening

Digestive and Liver Disease

S De Siervi

S Conti Nibali

S Mantovani

B Oliviero

MU Mondelli

...

2024/2/1

Long‐term dynamics of natural killer cells in response to SARS‐CoV‐2 vaccination: Persistently enhanced activity postvaccination

Journal of Medical Virology

Dalila Mele

Sabrina Ottolini

Andrea Lombardi

Daniela Conteianni

Alessandra Bandera

...

2024/4

" Actionable" host genetic markers for repurposing" add-on therapy" in COVID-19

European Journal of Human Genetics

C Fallerini

F Fava

M Baldassarri

S Scolletta

F Franchi

...

2023

Non‐tuberculous mycobacteriosis of the liver responsive to empiric therapy

Liver International

Luisa Siciliani

Alessandro Vanoli

Francesca Berton

Mario U Mondelli

2023/6

Hepatitis C Virus and the Host: A Mutual Endurance Leaving Indelible Scars in the Host’s Immunity

Mario U Mondelli

Sabrina Ottolini

Barbara Oliviero

Stefania Mantovani

Antonella Cerino

...

2023/12/23

Hematuria following overtreatment of subconjunctival hemorrhage with heparin eye drops

JFO Open Ophthalmology

Mario U Mondelli

Elena Antoniazzi

2023

Ceramide present in cholangiocarcinoma-derived extracellular vesicle induces a pro-inflammatory state in monocytes

Scientific Reports

Barbara Oliviero

Michele Dei Cas

Aida Zulueta

Roberta Maiello

Alessandro Villa

...

2023/5/12

Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study

Journal of Infection and Public Health

José Camilla Sammartino

Marta Colaneri

Cecilia Bassoli

Mariaelena Ceresini

Antonio Piralla

...

2023/5/1

VDAC1 selective molecules promote patients-derived cancer organoids death through mitochondrial-dependent metabolic interference

S De Siervi

A Magri

L Brocca

S Mantovani

B Oliviero

...

2023/12/5

TLRs: innate immune sentries against SARS-CoV-2 infection

Stefania Mantovani

Barbara Oliviero

Stefania Varchetta

Alessandra Renieri

Mario U Mondelli

2023/4/29

Does co-administration of vaccines interfere with immune responses? The jury is still out

Clinical Microbiology and Infection

Mario U Mondelli

2023/12/1

Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma

Digestive and Liver Disease

S De Siervi

S Conti Nibali

S Mantovani

B Oliviero

MU Mondelli

...

2023/3/1

Acute severe hepatitis of unknown aetiology in children: a new non-A–E hepatitis virus on horizon?

Clinical Microbiology and Infection

Gülşen Özkaya Şahin

Mario U Mondelli

Mojca Matičič

Oana Sandulescu

William Irving

2022/9/1

Infectious events in patients treated with immune checkpoint inhibitors, chimeric antigen receptor T cells, and bispecific T-cell engagers: a review of registration studies

Andrea Lombardi

Atil Saydere

Riccardo Ungaro

Giorgio Bozzi

Giulia Viero

...

2022/7/1

Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells

Cancers

Stefania Mantovani

Stefania Varchetta

Dalila Mele

Roberta Maiello

Matteo Donadon

...

2022/8/22

Early and polyantigenic CD4 T cell responses correlate with mild disease in acute COVID-19 donors

International journal of molecular sciences

Alison Tarke

Marina Potesta

Stefania Varchetta

Daniela Fenoglio

Marco Iannetta

...

2022/6/28

MICA/B-targeted antibody promotes NK cell–driven tumor immunity in patients with intrahepatic cholangiocarcinoma

Oncoimmunology

Barbara Oliviero

Stefania Varchetta

Dalila Mele

Greta Pessino

Roberta Maiello

...

2022/12/31

COVID-19 Host Genetics Initiative. A first update on mapping the human genetic architecture of COVID-19

Gita A Pathak

Renato Polimanti

Juha Karjalainen

Mark Daly

Andrea Ganna

...

2022/8/3

See List of Professors in * Mondelli Mario University(Università degli Studi di Pavia)